共 50 条
- [21] Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 557 - 559
- [22] Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan BMC Pharmacology and Toxicology, 25
- [27] Real-World Use of SGLT2 Inhibitors in Patients with CKD with and without Diabetes: A Population-Based Cohort Study JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
- [29] Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (09): : 1153 - 1162